智通财经网·2025-10-16 08:59Core Viewpoint - Johnson & Johnson (JNJ) is facing its first lawsuit in the UK regarding its talc products, which are alleged to cause cancer, while the company is already dealing with thousands of similar claims in the US [1][2] Group 1: Lawsuit Details - The lawsuit was filed in the High Court of England, naming Johnson & Johnson and its subsidiary Kenvue UK Limited as defendants [1] - Over 3,000 plaintiffs claim that using Johnson's baby powder from 1965 to 2023 led to ovarian cancer, mesothelioma, or other diseases [1] - KP Law asserts that Johnson's talc products contain carcinogenic fibers, including asbestos, which is linked to deadly mesothelioma [1] Group 2: Company Response and Legal Strategy - Johnson & Johnson has transferred inquiries to Kenvue and maintains that it has reserved liability for talc-related lawsuits outside the US and Canada [1] - Kenvue states that Johnson's baby powder "does not contain asbestos and is not carcinogenic" [1] - Johnson & Johnson stopped selling talc-based baby powder in the US in 2020 and switched to corn starch products, a similar move was made in the UK in 2023 [2] Group 3: Financial Implications - The estimated value of the UK lawsuit is around £1 billion (approximately $1.34 billion) [2] - A recent ruling in the US required Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, marking one of the largest penalties faced by the company [2] - Unlike the US, where punitive damages can be substantial, UK courts typically limit damages to compensatory amounts unless intentional harm is proven [2]